Renal Cell Carcinoma (RCC) Clinical Trials

Find Renal Cell Carcinoma (RCC) Clinical Trials Near You

Perfusion Mapping and Tissue Characterization Using Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with a kidney tumor ≤7cm

• planned robot-assisted partial nephrectomy

• age ≥ 18 years

Locations
Other Locations
Germany
University Hospital Leipzig
RECRUITING
Leipzig
Contact Information
Primary
Jens-Uwe Stolzenburg, Professor Dr.
jens-uwe.stolzenburg@medizin.uni-leipzig.de
+49 3419717600
Backup
Doreen Trebst, Dr.
doreen.trebst@medizin.uni-leipzig.de
+49 3419717610
Time Frame
Start Date: 2026-09-01
Estimated Completion Date: 2028-08
Participants
Target number of participants: 60
Related Therapeutic Areas
Sponsors
Leads: University of Leipzig

This content was sourced from clinicaltrials.gov